Zobrazeno 1 - 10
of 42
pro vyhledávání: '"E. N. Lebedenko"'
Autor:
A. A. Artyukhov, V. A. Golovachenko, S. M. Deev, B. V. Egorova, K. V. Kokov, T. M. Kuznetsova, A. V. Kurochkin, E. N. Lebedenko, K. A. Makoveeva, A. A. Pankratov, A. D. Plyutinskaya, M. A. Proshin, D. Yu. Chuvilin, A. A. Shulga, A. D. Kaprin
Publikováno v:
Nanobiotechnology Reports. 17:429-435
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37a47a94091eb81f6183d2b7308ebbd9
https://doi.org/10.1134/s2635167622030028
https://doi.org/10.1134/s2635167622030028
Autor:
G. M. Proshkina, S. M. Deev, P V Shegai, Konstantin Kokov, A D Kaprin, B V Egorova, Anna D. Plyutinskaya, A. A. Pankratov, V. A. Golovachenko, M S Vorontsova, E N Lebedenko, E. R. Nemtsova, D. Yu. Chuvilin, A. A. Shulga
Publikováno v:
Bulletin of Experimental Biology and Medicine. 171:627-632
Two radiopharmaceutical preparations were developed on the basis of artificial targeted polypeptide ZHER2 specific to HER2/neu tumor marker and radionuclides 177Lu (ZHER2-HSA-chelator-177Lu) or 212Pb (ZHER2-HSA-chelator-212Pb). The objective was to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b956afdc2d0b483ff906be90f549d47
https://doi.org/10.1007/s10517-021-05283-4
https://doi.org/10.1007/s10517-021-05283-4
Publikováno v:
Acta Naturae
Today, it has become apparent that innovative treatment methods, including those involving simultaneous diagnosis and therapy, are particularly in demand in modern cancer medicine. The development of nanomedicine offers new ways of increasing the the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5bc4dd3955c395b6e71ec3b2ff3ef70
https://doi.org/10.32607/actanaturae.11028
https://doi.org/10.32607/actanaturae.11028
Autor:
A A, Pankratov, E R, Nemtsova, A D, Plyutinskaya, M S, Vorontsova, D Yu, Chuvilin, B V, Egorova, K V, Kokov, S M, Deev, E N, Lebedenko, G M, Proshkina, A A, Shul'ga, V A, Golovachenko, P V, Shegai, A D, Kaprin
Publikováno v:
Bulletin of experimental biology and medicine. 171(5)
Two radiopharmaceutical preparations were developed on the basis of artificial targeted polypeptide ZHER2 specific to HER2/neu tumor marker and radionuclides
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a1b2cbe647842056ca49b878260f30f8
https://pubmed.ncbi.nlm.nih.gov/34626281
https://pubmed.ncbi.nlm.nih.gov/34626281
Autor:
S. M. Deyev, E. N. Lebedenko
Publikováno v:
Molecular Biology. 51:788-803
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff36a5c48348ac542c0f51e19bbdaaa4
https://doi.org/10.1134/s002689331706005x
https://doi.org/10.1134/s002689331706005x
Autor:
Sergey M. Deyev, E. N. Lebedenko
Publikováno v:
Молекулярная биология. :907-926
In this review, the authors' works published within the past 5 years devoted to the development of bifunctional hybrid nanostructures based on the targeting polypeptides and nanoparticles of various origin (quantum dots, nanogold, nanodiamonds, upcon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::142e95a099bb18b724bbebde8b5792cc
https://doi.org/10.7868/s0026898417060040
https://doi.org/10.7868/s0026898417060040
Autor:
Alexey A. Schulga, Olga M Kutova, G. M. Proshkina, E. N. Lebedenko, Sergey M. Deyev, E. A. Sokolova
Publikováno v:
Proceedings of the Scientific-Practical Conference "Research and Development-2016" ISBN: 9783319628691
Four variants of bifunctional HER2-specific recombinant proteins (anti-HER2-toxins) were created composed of HER2-specific scFv antibody (4D5scFv) or HER2-specific DARPin (D29) as targeting module and Pseudomonas exotoxin A fragment (PE40) as toxic m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b775189389a7e4454855838c24f6ac05
https://doi.org/10.1007/978-3-319-62870-7_59
https://doi.org/10.1007/978-3-319-62870-7_59
Autor:
E. N. Lebedenko, S. M. Deyev
Publikováno v:
Russian Journal of Bioorganic Chemistry. 41:481-493
This mini-review summarizes recent data obtained in the process of creation of a versatile module platform suitable for construction of supramolecular theranostic agents. As an example, we consider multifunctional hybrid agents for imaging and elimin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f5d7c01fcef26d3c792d69aede1c7df
https://doi.org/10.1134/s1068162015050052
https://doi.org/10.1134/s1068162015050052
Autor:
Lada E. Petrovskaya, E. N. Lebedenko, Dmitry A. Dolgikh, Mikhail P. Kirpichnikov, Sergey M. Deyev, Alexander G. Gabibov
Publikováno v:
Russian Chemical Reviews. 84:1-26
The review outlines progress and problems in the design of non-natural antibodies for clinical applications over the past 10–15 years. The modular structure of natural antibodies and approaches to its targeted modifications and combination with oth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56e8b27305a507b0d27e6efbf98dac6b
https://doi.org/10.1070/rcr4459
https://doi.org/10.1070/rcr4459
Autor:
S M, Deyev, E N, Lebedenko
Publikováno v:
Molekuliarnaia biologiia. 51(6)
In this review, the authors' works published within the past 5 years devoted to the development of bifunctional hybrid nanostructures based on the targeting polypeptides and nanoparticles of various origin (quantum dots, nanogold, nanodiamonds, upcon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dbbff1988d37554913ddc3852fd43d20
https://pubmed.ncbi.nlm.nih.gov/29271956
https://pubmed.ncbi.nlm.nih.gov/29271956